MASSACHUSETTS
-
SONESTA ANNOUNCES 50 NEW FRANCHISED HOTELS WITH 20 NEW FRANCHISEES SINCE THE BEGINNING OF 2022
Ownership Groups Commit to 20 Additional Franchises with Sonesta Brands NEWTON, Mass., June 6, 2022 /PRNewswire/ -- Sonesta International Hotels Corporation (Sonesta), one of the fastest-growing hospi…
-
Deadly Tulsa Hospital Shooting Renews Urgency for Stronger Violence Protection for Massachusetts Nurses and Healthcare Professionals as MNA Legislation Advances in House and Senate
Nurses and healthcare workers are assaulted more than police officers and prison guards, with the COVID-19 pandemic worsening threats and violence BOSTON, June 6, 2022 /PRNewswire/ -- Massachusetts la…
-
Reach Mobile Secures Additional $16 Million in Funding; Company Formally Announces ReachNEXT Platform to Deliver Next-Generation Network-Based Services
Total Raise for Reach Mobile is $35.6 Million to Date BOSTON, June 6, 2022 /PRNewswire/ -- Reach Mobile today formally announced the company has secured an additional $8...
-
Selux Diagnostics Announces Selection of Two Abstracts for Poster Sessions at ASM Microbe 2022 Conference
BOSTON, June 6, 2022 /PRNewswire/ -- Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced the…
-
K&R Solutions Group Celebrates 3-Year Anniversary With New Software, Partnerships & Sustainability Initiatives
BOSTON, June 6, 2022 /PRNewswire/ -- K&R Solutions Group, an ACDBE and DBE-certified woman-owned business celebrates its 3-year anniversary and launches its website. K&R Solutions Group is a Project M…
-
How to Cope with Loss? Grief Therapist Shares her Sister's Cancer Story
Gray Dove Press presents a deeply touching memoir of love and loss, as two sisters walk a perilous path that takes them to the edge of life. ARLINGTON, Mass., June 6, 2022 /PRNewswire/ -- A new book f…
-
Byrna Technologies Announces Preliminary Second Quarter Revenues of $11.5 Million.
Reiterates Full Year Revenue Guidance of $55-$60 Million ANDOVER, Mass., June 6, 2022 /PRNewswire/ -- Byrna Technologies Inc. (NASDAQ: BYRN) ("Byrna" or "the Company") today announced preliminary reve…
-
IDC Names OneView a Major Player for Worldwide Point-of-Sale Software Vendors
OneView innovation highlighted in the 2022 worldwide point-of-sale software grocery and food store retail vendor assessment. BOSTON, June 6, 2022 /PRNewswire/ -- OneView Commerce today announced that.…
-
Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform
Through real-time metabolite monitoring, Bitome's technology is expected to support accelerated product development timelines across Ginkgo's portfolio of cell programs BOSTON, June 6, 2022 /PRNewswir…
-
Akamai Launches New Malware Protection for Uploaded Files
Edge-based solution detects and blocks malicious files uploaded to web apps and APIs CAMBRIDGE, Mass., June 6, 2022 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that pow…
-
Aspen Aerogels, Inc. Provides Business Update
Accelerated Capital Investments Driven by EV Thermal Barrier Demand; Updated 2022 Financial Outlook NORTHBOROUGH, Mass., June 6, 2022 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the…
-
Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022
BOSTON, June 6, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has posted its full lineup of speakers planned for the Company's Investor Day, to be hosted in Boston on Wednesday, June 29, 20…
-
Jacobio Announces Phase I Clinical Data of KRAS G12C Inhibitor JAB-21822 at 2022 ASCO Annual Meeting
BEIJING and SHANGHAI and BOSTON, June 5, 2022 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced the phase I clinical data of KRAS G12C inhibitor JAB-21822 at the 2022 annual meeting of American Socie…
-
Curis Announces Encouraging Emavusertib Data at the 2022 American Society of Clinical Oncology Annual Meeting (ASCO)
TakeAim Lymphoma data for the combination of emavusertib plus ibrutinib show tumor reduction in 8 of 9 evaluable patients, including 2 complete responses and 2 partial responses Potential for overcomi…
-
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., June 3, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st…
-
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., June 3, 2022 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherap…
-
NanoMosaic Partners with BrickBio to Increase its Neurology Content with Novel Tau (Phospho-Thr217) Antibody
BOSTON, June 3, 2022 /PRNewswire/ -- NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in neurology companion d…
-
Akebia Therapeutics to Present at Jefferies Healthcare Conference
CAMBRIDGE, Mass., June 3, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today an…
-
T1D Exchange to Highlight New Real-World Findings Across 18 Presentations at the American Diabetes Association 82nd Scientific Sessions
– Company showcases breadth of capabilities and commitment to advancing health equity through diverse, compelling type 1 diabetes research –– Oral presentation on "Inequities in Glycemic Outcomes for…
-
Ardelyx to Present at the Jefferies 2022 Healthcare Conference
WALTHAM, Mass., June 3, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines…